NASDAQ · Drug Manufacturers - Specialty & Generic

Cronos Group Inc. - Common Share (CRON) Stock

$3.22 -0.62% NASDAQ: CRON Healthcare

Valuation

MetricValue
Price$3.22
Market Cap$1.20B
P/E Ratio17.44
P/B Ratio1.14
P/S Ratio6.83
EPS (TTM)$0.00
52-Week High$3.61
52-Week Low$2.28
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE6.46%
ROA5.91%
ROCE0.05%
Gross Margin42.19%
Operating Margin-7.77%
Net Margin38.95%
Debt/Equity0.00
Current Ratio19.67

Annual Financials (USD)

Metric20212022202320242025
Revenue$65.0M$87.0M$87.0M$118.0M$149.0M
Operating Profit$-292.0M$-111.0M$-85.0M$-77.0M$-18.0M
Net Profit$-396.0M$-169.0M$-74.0M$41.0M$-10.0M
EPS$-1.07$-0.45$-0.19$0.11$-0.03
Op Margin-452.2%-128.4%-97.2%-65.1%-12.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.4B$1.2B$1.1B$1.2B$1.2B
Total Liabilities$63.0M$72.0M$44.0M$55.0M$54.0M
Cash$887.0M$765.0M$669.0M$859.0M$792.0M
Borrowings$10.0M$4.0M$3.0M$2.0M$2.0M

Latest News

Cronos Group Inc. to Hold 2026 Second Quarter Earnings Conference Call on August 6, 2026 GlobeNewswire · Jul 16, 2026 TLRY Plans Strategic Medical Cannabis Expansion: Time to Buy or Sell? Zacks · Jul 2, 2026 Cronos Announces Appointment of ATB Cormark as its Broker for Share Repurchases in Canada GlobeNewswire · Jun 30, 2026 CRON Strengthens Global Footprint: Is the Cannabis Stock Worth Buying? Zacks · Jun 24, 2026 Cronos Group Inc. Announces Results of 2026 Annual Meeting of Shareholders GlobeNewswire · Jun 22, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-154.0M$-89.0M$-43.0M$19.0M$26.0M
Investing Cash Flow$-41.0M$-7.0M$-63.0M$162.0M$-104.0M
Financing Cash Flow$-13.0M$-3.0M$-1.0M$-1.0M$-20.0M
Net Cash Flow$-191.0M$-122.0M$-95.0M$190.0M$-68.0M
Free Cash Flow$-166.0M$-94.0M$-46.0M$6.0M$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA13.99
FCF Yield4.06%
Quick Ratio15.25
Interest Coverage0.00
Return 1Y31.10%
Return 3Y48.11%
Return 5Y-63.53%

Ownership

Insiders Held48.55%
Institutions Held15.64%
Institutions Float Held30.39%
Institutional HolderSharesReport Date
Chescapmanager LLC7,942,7372026-03-31
Shaw D.E. & Co., Inc.7,618,2272026-03-31
Pillsbury Lake Capital LLC4,223,0042026-03-31
Tidal Investments LLC4,026,8922026-03-31
Dimensional Fund Advisors LP2,679,0512026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AMPHAmphastar Pharmaceuticals, Inc. $25.81 +1.06% 14.50 $1.14B 0.00%
BBOTBridgeBio Oncology Therapeutics, Inc. $3.42 -0.58% -0.90 $273.97M 0.00%
COLLCollegium Pharmaceutical, Inc. $22.11 +0.82% 14.47 $717.11M 0.00%
EMBCEmbecta Corp. $5.75 -2.71% 3.97 $341.13M 0.68%
IRMDiRadimed Corporation $85.88 +0.48% 47.37 $1.10B 0.93%

About Cronos Group Inc. - Common Share

Cronos Group Inc. - Common Share is led by CEO Michael Ryan Gorenstein, employs 459 people, headquartered in CA, publicly traded since 2018.

Cronos Group Inc. - Common Share (CRON) stock trades at $3.22 with a market capitalization of $1.20B. The stock is valued at a price-to-earnings (P/E) ratio of 17.44, price-to-book of 1.14, price-to-sales of 6.83. Over the past 52 weeks the stock has ranged between $2.28 and $3.61, and currently trades 10.8% below its 52-week high.

On profitability, Cronos Group Inc. - Common Share generates a return on equity (ROE) of 6.46%, return on capital employed of 0.05%, an operating margin of -7.77%, a net profit margin of 38.95%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1169.93 -1.58% JNJ Johnson & Johnson $256.48 -0.76% ABBV AbbVie Inc. $272.42 +0.39% MRK Merck & Company, Inc. Common Stock (new) $142.40 -0.28% UNH UnitedHealth Group Incorporated Common Stock (DE) $370.95 -1.34% NVS Novartis AG $143.11 -0.12% AZN AstraZeneca PLC $158.78 -0.84% TMO Thermo Fisher Scientific Inc $651.98 -1.52% AMGN Amgen Inc. $407.44 -1.37% GILD Gilead Sciences, Inc. $147.10 +0.17% ABT Abbott Laboratories $98.49 -0.24% NVO Novo Nordisk A/S $38.18 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides